Clinical Interests
  • Attention deficit hyperactivity disorder (ADHD)
  • Juvenile mood and anxiety disorders
  • Autism spectrum disorders
Medical Education
  • MD, University of Buenos Aires School of Medicine
  • Residency, Hadassah University Hospital
  • Fellowship, Children's Hospital Boston|Fellowship, Massachusetts General Hospital
Board Certifications
  • Child & Adolescent Psychiatry
  • Psychiatry
Foreign Languages
  • Spanish
  • Hebrew
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Great-West Healthcare (formally One Health Plan)
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicare
  • Medicare - ACD
  • OSW - Maine
  • OSW - New Hampshire
  • Private Health Care Systems (PHCS)
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Behavioral Health
  • United Behavioral Health - MGH

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Pediatric and Adult

Edit Profile


Dr. Biederman is Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD at the Massachusetts General Hospital, Director of the Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorders at the Massachusetts General Hospital, and Professor of Psychiatry at the Harvard Medical School.  Dr. Biederman is Board Certified in General and Child Psychiatry.

Dr. Biederman has been a mentor to more than 15 junior investigators in the field.  He is on the editorial board of multiple journals, a reviewer for many Psychiatric journals, and has served as a grant reviewer in the Child Psychopathology and Treatment Review Committee of the NIMH.  Dr. Biederman is the author and co-author over 750 scientific articles, 650 scientific abstracts, and 70 book chapters.

In October 2007, Dr. Biederman was ranked as the second highest producer of high-impact papers in psychiatry overall throughout the world by the Institute for Scientific Information (ISI).  The same organization ranked Dr. Biederman at #1 in terms of total citations to his papers published on ADD/ADHD in the past decade. In 2014, Thompson Reuters named Dr. Biederman on their list of The World’s Most Influential Scientific Minds, as ranking in the top 1% by citations for the field of psychiatry.   Dr. Biederman's work is supported by multiple federal and pharmaceutical industry grants.

Edit Profile

Research & Publications


View my most recent publications at PubMed

Edit Profile

News & Events